EcoDrugPlus

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSONIG00000008733
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-6

Ensembl ID : ENSONIG00000002016
Gene Symbol: LOC102077017
2 Cross references
162 Possible Orthologues:

Intermediate Conductance Calcium-Activated Potassium Channel Protein 4

Ensembl ID : ENSONIG00000041858
Gene Symbol: LOC100704922
3 Cross references
187 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSONIG00000016369
Gene Symbol: IDH1
1 Cross references
232 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSONIG00000015176
Gene Symbol: LOC100707874
4 Cross references
207 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSONIG00000018066
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSONIG00000002960
Gene Symbol: KDR
4 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSONIG00000015463
Gene Symbol: KIF11
4 Cross references
201 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSONIG00000015032
Gene Symbol: KIF5B
4 Cross references
236 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSONIG00000003778
Gene Symbol: KIF5B
3 Cross references
234 Possible Orthologues:

Leukotriene A-4 Hydrolase

Ensembl ID : ENSONIG00000007586
Gene Symbol: LOC100705920
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor 1

Ensembl ID : ENSONIG00000035403
Gene Symbol: LOC100709071
3 Cross references
156 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).